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Abstract Senescent organisms respond poorly to hypoxic
stress. The transcription factor hypoxia-inducible factor 1
(HIF-1) plays a critical role in the coordinated genetic program
that is induced in all tissues to adapt to hypoxic stress by binding
to a specific DNA hypoxia-responsive recognition element
(HRE). This study was designed to address whether aging is
associated with an alteration in HIF-1 production and function.
Young and old mice were exposed to hypoxia for various lengths
of time. We found a severe impairment in the capacity of the old
animals to form a HIF-1-HRE complex. This attenuation in the
capacity to form HIF-1-HRE complexes in senescent tissues may
explain the decreased ability of such tissues to respond to
hypoxic stress.
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1. Introduction
One of the major characteristics of aging is the decline in
the capacity to respond to stress [1]. Hypoxia is a typical
stress to which senescent organisms respond poorly. One ex-
ample of this phenomenon in man is manifested as a de-
creased ability to tolerate and adapt to ischemic vascular dis-
ease in the elderly [2]. Recently, it has been demonstrated that
this impaired ability to adapt to ischemia in the elderly is in
part due to a reduction in the amount of angiogenesis respon-
sible for collateral blood vessel development [3]. This age-de-
pendent impairment of angiogenesis was shown to be medi-
ated by a decline in the production of vascular endothelial
growth factor (VEGF) [3]. The molecular alterations respon-
sible for this decline have not been fully elucidated.
Hypoxia-inducible factor 1 (HIF-1) [4] is a transcription
factor responsible for a coordinated genetic program [5] me-
diating such diverse but related functions as increased respi-
ratory rate, increased erythropoiesis, increased glycolysis and
increased angiogenesis all in response to organismal hypoxic
stress. These physiological responses to hypoxia are mediated
by speci¢c gene products whose transcription rates are in-
creased by HIF-1, notably the genes for tyrosine hydroxylase
[6], erythropoietin (Epo) [7], glycolytic enzymes [8] and VEGF
[9], respectively. Accordingly, in order to understand the mo-
lecular basis for the age-dependent impairment in responding
to hypoxic stress, the present study was designed to address
whether aging is associated with an alteration in HIF-1 pro-
duction and function.
2. Materials and methods
2.1. Animals
Young and old C57 Bl/6J female mice used in these studies were 2^
3 months and 24 months of age, respectively. The animal experimen-
tation protocols followed approved institutional guidelines.
2.2. Hypoxia
Hypoxia was achieved by subjecting animals to a mixture of 93%
N2 and 7% O2 for periods of 30 and 60 min in impermeable plastic
bags.
2.3. Preparation of nuclear extracts
Following exposure to hypoxia, the animals were killed by cervical
dislocation. Brains, lungs, kidneys and livers were frozen in liquid
nitrogen and kept at 380‡C until further use. Frozen tissues were
homogenized in three volumes of TKM bu¡er (5 mM Tris-HCl, pH
7.5, 2.5 mM KCl, 5.0 mM MgCl2, 0.5 mM DTT, 0.4 mM PMSF,
2 Wg/Wl aprotinin, 1 Wg/ml sodium vanadate and 2 Wg/ml leupeptin)
containing 0.25 M sucrose in a Potter-Elvenheim homogenizer [10].
The homogenate was ¢ltered through gauze and the ¢ltrate brought
up to 1.62 M sucrose and 0.5% NP-40. The preparation was then
centrifuged at 60 000Ug for 60 min and the pellet suspended in bu¡er
D (10 mM Tris-HCl, pH 7.9, 100 mM KCl, 2 mM MgCl2, 0.1 mM
EDTA, 0.5 mM DTT, 0.4 mM PMSF, 2 Wg/ml aprotinin, 1 Wg/ml
sodium vanadate and 2 Wg/ml leupeptin). Nuclear proteins were ex-
tracted according to Parker and Topol [11] with minor modi¢cations.
The suspension of nuclei in bu¡er D was brought up to 0.4 M
(NH4)2SO4 and incubated at 4‡C for 30 min. Subsequently, this prep-
aration was centrifuged in a Ti-50 rotor at 130 000Ug for 120 min.
The supernatant proteins were precipitated by the addition of 0.33 g/
ml (NH4)2SO4 and incubated at 4‡C for 30 min followed by centri-
fugation at 27 000Ug for 30 min.
2.4. Electromobility shift assay (EMSA)
EMSA was performed according to Semenza and Wang [12]. The
mutant and wild-type probe containing a HIF-1 binding site were
from the rat VEGF hypoxia-responsive recognition element (HRE)
[9]. The binding reaction was performed in a ¢nal volume of 20 Wl
binding bu¡er (¢nal concentration of 10 mM Tris-HCl, pH 7.5, 50
mM NaCl, 1 mM MgCl2, 1 mM EDTA, 5 mM DTT, 5% glycerol and
1 mM sodium vanadate). The reaction mixture also contained 5 Wg of
nuclear extract protein and 0.1 Wg denatured calf thymus DNA. The
reaction mixture was incubated at room temperature for 5 min prior
to the addition of 0.2 ng (104 cpm) radioactive probe. After an addi-
tional 15 min, the mixture was electrophoresed at 180 V on a 4%
acrylamide gel in 0.3UTBE. The gel was dried and the amount of
HIF-HRE complex quantitated by phosphorimager analysis.
2.5. Antibodies and Western blot
Monoclonal antibody to HIF-1K was provided by R.H. Wenger.
Western blot and ECL (Amersham) were performed according to the
manufacturer’s protocol.
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3. Results
3.1. Establishment of speci¢city of the EMSA system for
HIF-1
Using a radioactively labelled 36 bp DNA fragment corre-
sponding to the rat HRE, we were able to demonstrate the
existence of a hypoxia-inducible protein complex in nuclear
extracts (Fig. 1A), similar to that previously described [9].
Speci¢city of binding due to HIF-1 was demonstrated using
a DNA fragment in which the HIF-1 site was mutated (Fig.
1A). Excess cold competitor HRE eliminated the formation of
the complex as previously described [9] (data not shown).
Finally, antiserum directed against HIF-1K was able to e⁄-
ciently supershift the hypoxia-inducible complex (Fig. 1B).
3.2. Hypoxia results in an attenuation of HIF-1 binding activity
in extracts from old compared to young animals
EMSA assays were performed with nuclear extracts pre-
pared from the tissues of young and old animals subjected
to 30 or 60 min hypoxia. We found a highly reproducible
marked age-associated decrease in HIF-HRE complex forma-
tion in brain, lung, kidney and liver (Fig. 2A^D).
3.3. The attenuation of HIF-1 binding activity with aging is not
due to decreased HIF-1 levels
In order to determine if the decreased amount of HIF-HRE
complex formed in aged animals was due to decreased HIF-1
levels, we performed Western blot analysis with an antibody
to HIF-1 on the same nuclear extracts used in the EMSA. In
the brain, we found, unexpectedly, that the level of HIF anti-
gen was higher in older animals than in younger animals
under normoxic conditions (Fig. 3A). Under hypoxic condi-
tions, HIF antigen was increased in the young animals, but
remained the same in the old animals. These results support
the contention that the failure to increase the HIF-HRE com-
plex in older animals is not due to less HIF protein but rather
due to loss of the ability of HIF to bind to the HRE. In the
liver, we found no di¡erence between the level of HIF-1 anti-
gen present in young and old animals exposed to hypoxia
(Fig. 3B). These results further support the notion that the
decrease in HIF-HRE complex seen in old animals is not due
to a decrease in HIF protein.
4. Discussion
Aging is associated with a marked impairment in hypoxia-
induced angiogenesis and anemia-induced erythropoiesis due
to a reduced production of VEGF [3] and Epo [13], respec-
tively. HIF-1 mediates the transcriptional activation of both
VEGF and Epo [9]. This study provides for the ¢rst time a
molecular explanation for the impaired formation of these
cytokines by hypoxia. Speci¢cally, we have shown that in
aged animals, HIF-1 has a reduced ability to bind to the
HRE present in these genes. Such a post-translational loss
of function has previously been described with aging for other
proteins [14,15]. This was related to an age-associated impair-
ment in protein degradation [16,17] possibly due to an alter-
ation in the functioning of the ubiquitin-proteasome complex
[18]. Interestingly, HIF-1K is regulated by hypoxia at the level
of its protein stability [5] with the tumor suppressor VHL
functioning as the ubiquitin ligase for HIF-1K [19].
Identi¢cation of the molecular mechanism responsible for
the loss of the ability to adapt to hypoxic stress provides a
molecular target for a rational pharmacological strategy to
restore the ability to respond to this stress in the elderly and
to concomitantly reduce morbidity from many disorders. In-
deed, in light of the known increase in susceptibility to oxi-
dative stress in the elderly [1] and the ability of oxidative stress
Fig. 1. Establishment of speci¢city of binding of HIF-1 to the HRE. (A) DNA EMSA performed with hypoxic and normoxic nuclear extracts
using the wild-type or mutant HRE (wt, wild-type HRE sequence; m, mutant HRE sequence; N, normoxia; H, hypoxia; Con., constitutive).
(B) Supershift of HIF-HRE complex with HIF-1K antibody.
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Fig. 2. Quantitation of HRE-HIF complex formation by EMSA in young and old animals exposed to hypoxia. Representative EMSAs are
from brain (A), lung (B), kidney (C) and liver (D). The results are quantitated in the histogram (Y, young; O, old). The data for each time
point represent the mean þ S.E.M. obtained from at least three animals (the actual number of animals is indicated on the histogram) with the
results normalized to the zero time point for young animals. *, Signi¢cant di¡erence (P6 0.05) between young and old animals at the time
point indicated.
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to diminish HIF-1 binding [5], it is tempting to speculate that
anti-oxidant therapy might prevent the loss of function of
HIF-1 in the elderly.
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Fig. 3. Western blot of HIF-1K antigen in nuclear extracts taken
from (A) brain and (B) liver of young and old animals exposed to
hypoxia. Equivalent amounts of nuclear extract were used for all
lanes except for the ¢rst lane in which recombinant HIF-1K protein
was used.
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